Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $14.5850 (1.32%) ($14.5850 - $14.5850) on Wed. Aug. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.62% (three month average) | RSI | 41 | Latest Price | $14.5850(1.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -3.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) ARKK(37%) IWO(37%) SKYY(36%) | Factors Impacting BCRX price | BCRX will decline at least -1.81% in a week (0% probabilities). VIXM(-22%) UUP(-15%) VXX(-7%) TBT(-3%) IGOV(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.81% (StdDev 3.62%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $4.95(-66.06%) | Resistance Level | $16.35 | 5 Day Moving Average | $15.41(-5.35%) | 10 Day Moving Average | $16.01(-8.9%) | 20 Day Moving Average | $16.35(-10.8%) | To recent high | -17.6% | To recent low | 9.8% | Market Cap | $2.573b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |